US HB1570 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 215-130)
Status: Engrossed on December 10 2020 - 50% progression, died in committee
Action: 2020-12-10 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on December 10 2020 - 50% progression, died in committee
Action: 2020-12-10 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Modifies cost-sharing requirements for colorectal cancer screening tests, and drug manufacturer reporting requirements, under Medicare medical services. Specifically, the bill waives coinsurance requirements with respect to colorectal cancer screening tests, regardless of the code billed for a resulting diagnosis or procedure. The bill phases in implementation over an eight-year period. Additionally, manufacturers of covered drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.
Title
Removing Barriers to Colorectal Cancer Screening Act of 2020
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2020-12-10 | Senate | Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| 2020-12-09 | House | The title of the measure was amended. Agreed to without objection. |
| 2020-12-09 | House | Motion to reconsider laid on the table Agreed to without objection. |
| 2020-12-09 | House | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7083-7084) |
| 2020-12-09 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 1570. |
| 2020-12-09 | House | Considered under suspension of the rules. (consideration: CR H7083-7086) |
| 2020-12-09 | House | Mr. Pallone moved to suspend the rules and pass the bill, as amended. |
| 2019-03-08 | House | Sponsor introductory remarks on measure. (CR H2608) |
| 2019-03-07 | House | Referred to the Subcommittee on Health. |
| 2019-03-06 | House | Referred to the Subcommittee on Health. |
| 2019-03-06 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2019-03-06 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2019-03-06 | House | Introduced in House |
Same As/Similar To
SB668 (Same As) 2019-03-06 - Read twice and referred to the Committee on Finance.
HB2339 (Related) 2020-03-02 - Received in the Senate and Read twice and referred to the Committee on Finance.
HB2087 (Related) 2019-05-21 - Subcommittee Hearings Held.
SB2051 (Related) 2019-06-28 - Read twice and referred to the Committee on Finance.
HB2339 (Related) 2020-03-02 - Received in the Senate and Read twice and referred to the Committee on Finance.
HB2087 (Related) 2019-05-21 - Subcommittee Hearings Held.
SB2051 (Related) 2019-06-28 - Read twice and referred to the Committee on Finance.
